Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
8.21
+0.48 (6.21%)
At close: Jan 7, 2026, 4:00 PM EST
8.21
0.00 (0.00%)
After-hours: Jan 7, 2026, 4:15 PM EST
Profound Medical Market Cap
Profound Medical has a market cap or net worth of $280.81 million as of January 7, 2026. Its market cap has increased by 61.29% in one year.
Market Cap
280.81M
Enterprise Value
260.54M
1-Year Change
61.29%
Ranking
Category
Stock Price
$8.21
Market Cap Chart
Since October 30, 2019, Profound Medical's market cap has increased from $113.60M to $280.81M, an increase of 147.19%. That is a compound annual growth rate of 15.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 233.40M | -1.77% |
| Dec 31, 2025 | 237.60M | 28.29% |
| Dec 31, 2024 | 185.20M | 2.09% |
| Dec 29, 2023 | 181.40M | -20.19% |
| Dec 30, 2022 | 227.30M | -2.53% |
| Dec 31, 2021 | 233.20M | -42.21% |
| Dec 31, 2020 | 403.50M | 210.86% |
| Dec 31, 2019 | 129.80M | 14.26% |
| Oct 30, 2019 | 113.60M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 982.67B |
| Johnson & Johnson | 498.19B |
| AbbVie | 404.55B |
| UnitedHealth Group | 309.15B |
| AstraZeneca | 293.89B |
| Merck & Co. | 269.32B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |